RESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop liver cancer return after surgery
Disease control OngoingThis study tests whether giving two drugs (atezolizumab and bevacizumab) before surgery can help prevent liver cancer from coming back. It involves 16 adults with liver cancer that can be surgically removed. The drugs work by boosting the immune system and blocking tumor blood su…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 06:08 UTC
-
New combo shrinks liver tumors before surgery in early trial
Disease control OngoingThis early-phase study tests whether giving focused radiation and two immunotherapy drugs before surgery can safely help treat liver cancer that can be removed. About 20 adults with resectable hepatocellular carcinoma will receive stereotactic body radiation therapy (SBRT) follow…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 26, 2026 06:04 UTC
-
Blood test could spot returning liver cancer sooner
Knowledge-focused OngoingThis study tests a new blood test that looks for DNA changes to find leftover or returning liver cancer after surgery. About 36 adults with early-stage liver cancer will give blood samples before and after treatment. The goal is to see if the test can catch cancer coming back ear…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 26, 2026 05:58 UTC